NYSE:LLYPharmaceuticals
Eli Lilly (LLY) Net Margin Surge Tests Justification For Premium 48x P/E
Eli Lilly (LLY) just closed out FY 2025 with fourth quarter revenue of US$19.3b and basic EPS of US$7.39, capping a year where trailing twelve month revenue reached US$65.2b and EPS came in at US$22.95. Over the last six reported quarters, revenue has moved from US$13.5b in Q4 2024 to US$19.3b in Q4 2025, while quarterly EPS shifted from US$4.88 to US$7.39 as the business scaled. With trailing net profit margins sitting well above last year and earnings growth outpacing revenue, the latest...